Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
abetted, adult, aided, Alabama, altogether, APP, Arizona, biopharmaceutical, biotechnology, borrowing, brand, breached, ceasing, CHMP, comparison, confirmed, consideration, contemplated, cow, customary, dairy, Dakota, downgrade, EDNY, enabled, exploring, failed, Fee, fiduciary, firm, goal, hand, Hawaii, hearing, hypertension, ImClone, Island, knowingly, Lafayette, Maryland, Medicinal, metastatic, mission, Missouri, Monsanto, NAACP, Nebraska, Nevada, NSCLC, Ohio, Oklahoma, oncolytic, order, Oregon, PAH, Parenteral, Posilac, Princeton, proven, pulmonary, purportedly, pursue, recommending, resolve, revolving, Rhode, short, sometribove, spanning, stabilized, successfully, suspended, tadalafil, tender, tendered, Tennessee, Tippecanoe, Transnational, twelve, unchanged, upfront, Vermont, weakening, Wisconsin, wrongdoing, ZypadheraTM
Filing tables
Filing exhibits
Related press release
LLY similar filings
Filing view
External links
EXHIBIT 11. STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
(Unaudited)
Eli Lilly and Company and Subsidiaries
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
(Dollars and shares in millions except per-share data) | ||||||||||||||||
BASIC | ||||||||||||||||
Net income (loss) | $ | (465.6 | ) | $ | 926.3 | $ | 1,557.5 | $ | 2,098.6 | |||||||
Average number of common shares outstanding | 1,092.2 | 1,089.1 | 1,091.9 | 1,088.8 | ||||||||||||
Contingently issuable shares | 1.8 | 1.0 | 2.0 | 1.0 | ||||||||||||
Adjusted average shares | 1,094.0 | 1,090.1 | 1,093.9 | 1,089.8 | ||||||||||||
Basic earnings (loss) per share | $ | (.43 | ) | $ | .85 | $ | 1.42 | $ | 1.93 | |||||||
DILUTED | ||||||||||||||||
Net income (loss) | $ | (465.6 | ) | $ | 926.3 | $ | 1,557.5 | $ | 2,098.6 | |||||||
Average number of common shares outstanding | 1,092.2 | 1,089.1 | 1,091.9 | 1,088.8 | ||||||||||||
Incremental shares — stock options and contingently issuable shares | 1.8 | 1.1 | 2.0 | 1.3 | ||||||||||||
Adjusted average shares | 1,094.0 | 1,090.2 | 1,093.9 | 1,090.1 | ||||||||||||
Diluted earnings (loss) per share | $ | (.43 | ) | $ | .85 | $ | 1.42 | $ | 1.93 | |||||||